Final answer:
A patient experiencing daily asthma symptoms, a PM cough four times a week, and an FEV1 less than 60% should seek medical attention for a potential step-up in asthma therapy. This could include inhaled corticosteroids, long-acting beta agonists, and fast-acting bronchodilators as needed for acute symptoms, along with strategies to avoid environmental triggers.
Step-by-step explanation:
Treatment for a patient with daily asthma symptoms and a post-meridian (PM) cough approximately four times a week, plus an FEV1 less than 60%, would consist of a step-up in asthma therapy, potentially including inhaled corticosteroids, long-acting beta agonists, and possibly oral medications. Immediate medical consultation is advisable due to the severity indicated by low FEV1.
Asthma is a chronic condition characterized by inflammation of the airways, which results in symptoms like wheezing, chest tightness, shortness of breath, and coughing, especially at night or early in the morning. The Forced Expiratory Volume in 1 second (FEV1) is used to assess the severity of airway obstruction, with values below 80% typically signaling a more severe condition that may require intensified treatment.
In the scenario described, with the patient experiencing symptoms daily and subpar FEV1 levels, a proactive approach is paramount. Maintenance therapy, including inhaled corticosteroids and long-acting beta agonists, would likely be recommended, and for acute exacerbations, fast-acting bronchodilators via an inhaler or nebulizer might be used. It's also critical to identify and avoid possible triggers such as allergens, air pollution, and tobacco smoke to prevent exacerbation of symptoms. Ultimately, a personalized asthma action plan should be created in partnership with a healthcare provider.